Related content

Improvement of Erdheim–Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil

By Jendro Michael   Zeidler Henning   Rosenthal Herbert   Haller Hermann   Schwarz Anke  

Clinical Rheumatology, Vol. 23, Iss. 1, 2004-02 ,pp. : 52-56

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus

By Weng Meng-Yu   Weng Chia-Tse   Liu Ming-Fei  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 771-775

Springer Publishing Company

Access to resources Recommend Favorite

Mycophenolate Mofetil: A New Immunosuppressive ApproachSuccessful Treatment in a Case of Myasthenia gravis Associated with Incomplete Lupus erythematosus Syndrome and Hepatitis C Virus Infection

By  

European Neurology, Vol. 46, Iss. 1, 2001-07 ,pp. : 53-54

Karger

Access to resources Recommend Favorite

The effectiveness and safety of mycophenolate mofetil in lupus nephritis

By Elyan Mazen   Ballou Stanley  

Clinical Rheumatology, Vol. 28, Iss. 7, 2009-07 ,pp. : 835-840

Springer Publishing Company

Access to resources Recommend Favorite

Mycophenolate Mofetil for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

By  

European Neurology, Vol. 56, Iss. 1, 2006-09 ,pp. : 37-38

Karger

Access to resources Recommend Favorite